MPH Health Care AG, DE000A289V03

MPH Health Care AG / DE000A289V03

30.04.2025 - 08:30:03

 Equity (NAV) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%.

MPH Health Care AG / Key word(s): Preliminary Results/Quarter Results


30.04.2025 / 08:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


MPH Health Care AG publishes preliminary figures for the 2024 financial year:  Equity (net asset value) increases by almost EUR 27 million to EUR 277.9 million, corresponding to EUR 64.90 per share. EBIT increases by EUR 2.75 million to EUR 33.0 million. The equity ratio rises to 95.5%. Berlin, 30th April 2025 - MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated result for the 2024 financial year. Accordingly, equity increased by 10.7% from EUR 251.0 million to EUR 277.9 million. The net asset value (NAV) per share rose from EUR 58.62 (31 December 2023) to EUR 64.90 as of 31 December 2024. In the 2024 financial year, preliminary EBIT increased by 9.1% to EUR 33.0 million (previous year: EUR 30.2 million). The IFRS net profit for the year rose from EUR 29.5 million to EUR 32.0 million. As of 31 December 2024, equity increased by EUR 26.9 million to EUR 277.9 million (previous year: EUR 251.0 million). The equity ratio rose from 94.2% to 95.5% and remains at a very high level. MPH AG is an investment company whose investments are recognised as financial assets under the balance sheet item "Financial assets" and are measured at “fair value through profit or loss” at the balance sheet date. The net profit for the year is mainly the result of the fair value measurement of the listed investments held as of the balance sheet date, which result from the higher market prices of the investments compared to the previous year's balance sheet date.  „Despite the current trade disputes with the USA and the ongoing conflict situation in Ukraine, we are confident about developments in 2025. The M1-Group plans to systematically continue its profitable growth by further expanding national and international specialist centres. By 2029, annual sales of EUR 200 to 300 million with an EBIT margin of at least 20% are targeted in the core ‘Beauty’ segment. With its vertically integrated investment portfolio, CR Energy AG is well positioned in the areas of ‘sustainable energy supply concepts’ and ‘quality and cost-optimised living space’. MPH AG can also systematically benefit from the positive developments of the investments in the coming years," says Patrick Brenske, CEO of MPH.   About MPH Health Care AG: MPH Health Care AG is an investment company with a strategic focus on the acquisition, development and sale of companies and company shares, particularly in growth segments of the healthcare market. This includes both insurance-financed and privately financed segments. However, MPH also utilises the potential offered by high-growth and profitable sectors outside the healthcare market.


Contact:
Patrick Brenske, Management Board
Corporate Communications
E-Mail: ir@mph-ag.de


30.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: 030 / 863 21 45 60
Fax: 030 / 863 21 45 69
E-mail: info@mph-ag.de
Internet: www.mph-ag.de
ISIN: DE000A289V03, DE000A289VT5
WKN: A289V0
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2127140

 
End of News EQS News Service

2127140  30.04.2025 CET/CEST
@ dgap.de